Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001104659-23-104808

Director bought 30,000 shares at $13.15 ($394,500)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2023-09-26 Purchase +30,000 $13.15 $394,500 1,903,833 I
Open-market purchases · 30,000 sh · avg $13.15 · $394,500
Loading xslF345X05/tm2327182-1_4seq1.xml…